We pick the stocks, we start the research, you ring the register!
          |
5-1-2006 TBV -Tines Biotech Group USA Inc.
CURRENT PRICE: $6.04
TYPE OF PLAY: EARNINGS GROWTH/TECHNICAL ANALYSIS/VALUE
TBV is a company with its main operations in China through its' 80% owned subsidiary Tianjin Tianshi Biological Development Co., Ltd. ("Biological"). Biological has developed and produced 39 nutrition supplements, which include wellness products and dietary nutrition supplements. Biological has also developed and produced 25 personal care products, which include skin care products and personal washing products. In their most recent quarterly report, TBV posted around 40% year over year revenue gains (~$18 million versus ~$13 million in the same quarter of previous year) and nearly double net income (~$5.5 million or .08 per share versus ~$3 million or .04 per share in the same quarter of the previous year. This robust growth was largely due to the addition of 40 new branches in China. The company's gross profit margins increased to an impressive 73%. TBV also has a very strong balance sheet. Their total cash on hand is over $77.5 million and debt is less than $10 million. The current EPS of .41 gives TBV a trailing P/E ratio of fewer than 15 also remains very low for a growth company. The stock is currently in an established uptrend and we expect that the lower trend line and the moving averages continue to be a source of support for the stock.
LINKS FOR FURTHER READING:
TBV Hompage
Tianjin Tianshi Group Homepage
Most recent TBV earnings filing
SEC filings for TBV
General TBV statistics
